Epstein Secrets

44532 EFTA02574066 "People are shocked whe= they hear that a bag of saline solution costs far less than their cup of =offee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that ma=e nearly all the IV solutions used in the United State

upled. Although alternatives are growing rapidly, pip=lines and oceangoing tankers remain the primary method for delivering crud= to refineries. In the Eagle Ford, a larg= four-year-old South Texas oil field, production has grown to more than 50=,000 barrels a day, from less than 1,000 in 2009, according to st

rupled. Although alternatives are growing rapidly, pipelines and oceangoing tankers remain the primary method for delivering crude to refineries. In the Eagle Ford, a large four-year-old South Texas oil field, production has grown to more than 500,000 barrels a day, from less than 1,000 in 2009, according to sta

hillips 66 began putting some of this crude on ships for a 2,200-mile journey around Florida to its refinery in Linden, N.J. The heavy trucks moving Eagle Ford crude are causing headaches for residents and local officials, ripping up roads and causing traffic tie-ups. "These are rural roads built for 10 car

ted States each year. “People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning,” said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States

drupled. Although alternatives are growing rapidly, pipelines and oceangoing tankers remain the primary method for delivering crude to refineries. In the Eagle Ford, a large four-year-old South Texas oil field, production has grown to more than 500,000 barrels a day, from less than 1,000 in 2009, according to sta

ited States each year. "People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States